98%
921
2 minutes
20
Background: People with HIV (PWH) frequently experience chronic pain, which negatively impacts their health and functioning. To improve health outcomes, we need effective interventions for HIV-related chronic pain. Skills TO Manage Pain (STOMP), a novel pain self-management intervention tailored for PWH and chronic pain, has demonstrated efficacy in reducing pain impact (measured by the Brief Pain Inventory) and improving pain self-efficacy immediately after a 12-week intervention and three months later.
Setting: We conducted this study at two Center for AIDS Research Network of Integrated Clinical Systems clinics.
Methods: We evaluated the efficacy of STOMP across 12 months by comparing trajectories of pain impact and pain self-efficacy among 244 adults (49% female, Mage = 53.62) randomized equally to the STOMP intervention or an Enhanced Usual Care (EUC) control condition. We also examined whether pain self-efficacy is a mechanism of change that helps explain how STOMP affects pain impact.
Results: Over 12 months, individuals who participated in STOMP reported lower pain impact and higher pain self-efficacy than those in EUC. Over time, the difference in pain impact attenuated slightly between the two groups but remained statistically significant. Pain self-efficacy remained significantly higher for the STOMP group. Individuals in STOMP showed greater improvements in their confidence to manage pain than those in EUC, resulting in less severe pain and reduced interference in daily life.
Conclusions: STOMP is an efficacious chronic pain intervention for PWH, improving pain outcomes one year later. Future research should evaluate mechanisms of change and best practices for implementing STOMP.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/QAI.0000000000003739 | DOI Listing |
Eur J Neurol
September 2025
Pain Treatment and Evaluation Center, CHU Timone, Assistance Publique des Hôpitaux de Marseille, Marseille, France.
Background: Neuropathic pain (NP) is frequently resistant to conventional treatments. Botulinum toxin type A (BT-A) is a recommended option for focal peripheral NP, but the dynamics of its effect in real-life conditions remain poorly characterized.
Objective: To assess BT-A efficacy in a real-world study of patients with focal peripheral NP, over a 1-year follow-up period.
Cancer Manag Res
September 2025
Department of Pain, The First People's Hospital of Zunyi City, Zunyi, Guizhou, 563000, People's Republic of China.
Objective: To evaluate the effects of a comprehensive intervention program on cancer pain and self-efficacy in patients with lung cancer.
Methods: A total of 120 lung cancer patients with cancer pain who received treatment from January 2021 to December 2023 at The First People's Hospital of Zunyi were enrolled in this study. A within-subject design was used, comparing patients' pain and self-efficacy scores before and after a comprehensive intervention.
Lasers Surg Med
September 2025
Department of Dermatology, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Objectives: Post-acne erythema (PAE), a common consequence of acne, is characterized by capillary dilation and erythema, which significantly impact facial aesthetics and quality of life. This study aims to evaluate and compare the efficacy and safety of intense pulsed light (DPL) and 1064 nm Q-switched Nd:YAG laser in treating PAE.
Methods: This prospective, randomized, self-controlled, evaluator-blinded clinical trial compared DPL and 1064 nm Q-switched Nd:YAG laser treatments on one side of the face, with biweekly sessions for 6 weeks.
Behav Res Ther
September 2025
Curtin School of Allied Health, Curtin University, Perth, Australia.
Chronic low back pain (CLBP) is an urgent global health priority given its high prevalence and impact as the leading cause of disability. While several efficacious treatments exist, most have modest effects. Improving outcomes requires a better understanding of treatment mechanisms to enable optimisation.
View Article and Find Full Text PDFNurs Res
September 2025
College of Nursing & Institute of Nursing Research, Korea University, Seoul, South Korea.
Background: Existing research fails to address the complex nature of nonspecific chronic lower back pain (cLBP ) despite its detrimental effect on economic, societal, and medical expenditures.
Objectives: We developed a nurse-led, mobile-delivered self-management intervention-Problem-Solving Pain to Enhance Living Well (PROPEL-M)-and evaluated its usability, feasibility, and initial efficacy for South Korean adults with nonspecific cLBP.
Methods: This study was composed of two phases: (a) lab and field usability testing for a gamified mobile device application; and (b) a pilot study employing a one-arm pre-test and post-test design among adults aged 18-60 years with nonspecific cLBP.